NASDAQ: RPRX
Royalty Pharma PLC Stock Ownership - Who owns Royalty Pharma?

Insider buying vs selling

Have Royalty Pharma PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Marshall UristEVP Research Investments2026-07-019,099$55.88
$508.45kSell
Christopher HiteEVP Chairman Partnering2026-06-3029,400$56.44
$1.66MSell
Christopher HiteEVP Chairman Partnering2026-06-302,554$57.10
$145.84kSell
Bonnie L. BasslerDirector2026-06-30689$54.40
$37.48kBuy
Christopher HiteEVP Chairman Partnering2026-06-30600$57.09
$34.25kSell
Christopher HiteEVP Chairman Partnering2026-06-3097,446$56.50
$5.51MSell
Marshall UristEVP Research Investments2026-06-249,098$55.18
$502.06kSell
Christopher HiteEVP Chairman Partnering2026-06-2332,408$54.11
$1.75MSell
Christopher HiteEVP Chairman Partnering2026-06-23117,592$54.48
$6.41MSell
Terrance P. CoyneEVP CFO2026-05-2664,399$53.98
$3.48MSell

1 of 8

RPRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPRX insiders and whales buy or sell their stock.

RPRX Shareholders

What type of owners hold Royalty Pharma PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Morgan Stanley7.57%43,571,633$2.56BInstitution
Adage Capital Partners GP LLC6.72%38,714,280$2.28BInsider
Capital International Investors6.08%35,005,736$2.06BInstitution
Blackrock Inc4.50%25,907,745$1.52BInstitution
Fmr LLC4.37%25,152,242$1.48BInstitution
1978 Sicaf Sif Sa 1. Gg3.83%22,081,156$1.30BInsider
1978 Sicaf Sif Sa Gg3.72%21,426,170$1.26BInsider
Baillie Gifford Co2.81%16,155,677$950.44MInstitution
Swedbank Ab2.01%11,586,693$681.65MInstitution
State Street Corp1.91%10,989,851$646.53MInstitution

1 of 3

RPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPRX62.11%17.27%Net SellingNet Selling
ONC2.41%31.88%Net SellingNet Selling
ALNY82.21%17.79%Net SellingNet Buying
RVMD91.08%8.92%Net SellingNet Selling
ROIV44.31%55.69%Net SellingNet Selling

Royalty Pharma Stock Ownership FAQ

Who owns Royalty Pharma?

Royalty Pharma (NASDAQ: RPRX) is owned by 62.11% institutional shareholders, 17.27% Royalty Pharma insiders, and 20.62% retail investors. Adage Capital Partners GP LLC is the largest individual Royalty Pharma shareholder, owning 38.71M shares representing 6.72% of the company. Adage Capital Partners GP LLC's Royalty Pharma shares are currently valued at $2.28B.

If you're new to stock investing, here's how to buy Royalty Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.